Robert Lyne Chief Operating Officer and GC at Arix Bioscience discusses the highlights from their Final Results.

Robert Lyne Chief Operating Officer and GC at Arix Bioscience #ARIX discusses the highlights from their Final Results.

Arix Bioscience is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.

We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks needed to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.